Ferronova raises AU$11M to progress nanoparticle platform to target malignant tumors

Great to be doubling down on Ferronova in their latest A$11m raise led by leading contrast-dye manufacturer Renew Health Limited. and alongside Uniseed & Artesian (Alternative Investments).

The additional $3m in funding from the Co-operative Research Centres Project (CRC-P) grant, is a testament to Ferronova’s game changing innovation in image guided surgery for gastrointestinal and brain cancers.

Congratulations on another big milestone 🎉

Read more below 👇